Paying users zone. Data is covered by 
.
Get 1 month access to Eli Lilly & Co. for $17.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
Eli Lilly & Co. (LLY)
Common-Size Income Statement
Quarterly Data
Difficulty: Beginner
Eli Lilly & Co., Common-Size Consolidated Income Statement (quarterly data)
Based on: 10-Q (filing date: 2019-05-02), 10-K (filing date: 2019-02-19), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-20), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-05-01), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-29), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-10-30), 10-Q (filing date: 2015-07-30), 10-Q (filing date: 2015-04-30), 10-K (filing date: 2015-02-19), 10-Q (filing date: 2014-10-29), 10-Q (filing date: 2014-07-28), 10-Q (filing date: 2014-04-28).
| Item | Description | The company |
|---|---|---|
| Operating income (loss) | The net result for the period of deducting operating expenses from operating revenues. | Eli Lilly & Co.’s operating income (loss) as a percentage of revenue declined from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019. |
| Income before income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Eli Lilly & Co.’s income before income taxes as a percentage of revenue declined from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019. |
| Net income (loss) | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Eli Lilly & Co.’s net income (loss) as a percentage of revenue declined from Q3 2018 to Q4 2018 but then increased from Q4 2018 to Q1 2019 exceeding Q3 2018 level. |